BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20346662)

  • 1. The development and validation of a novel virtual screening cascade protocol to identify potential serotonin 5-HT(7)R antagonists.
    Kurczab R; Nowak M; Chilmonczyk Z; Sylte I; Bojarski AJ
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2465-8. PubMed ID: 20346662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New serotonin 5-HT(6) ligands from common feature pharmacophore hypotheses.
    Kim HJ; Doddareddy MR; Choo H; Cho YS; No KT; Park WK; Pae AN
    J Chem Inf Model; 2008 Jan; 48(1):197-206. PubMed ID: 18044950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel serotonin 2C receptor ligands by sequential virtual screening.
    Ahmed A; Choo H; Cho YS; Park WK; Pae AN
    Bioorg Med Chem; 2009 Jul; 17(13):4559-68. PubMed ID: 19464901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives.
    López-Rodríguez ML; Porras E; Morcillo MJ; Benhamú B; Soto LJ; Lavandera JL; Ramos JA; Olivella M; Campillo M; Pardo L
    J Med Chem; 2003 Dec; 46(26):5638-50. PubMed ID: 14667218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
    Holenz J; Mercè R; Díaz JL; Guitart X; Codony X; Dordal A; Romero G; Torrens A; Mas J; Andaluz B; Hernández S; Monroy X; Sánchez E; Hernández E; Pérez R; Cubí R; Sanfeliu O; Buschmann H
    J Med Chem; 2005 Mar; 48(6):1781-95. PubMed ID: 15771424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas.
    Li HF; Lu T; Zhu T; Jiang YJ; Rao SS; Hu LY; Xin BT; Chen YD
    Eur J Med Chem; 2009 Mar; 44(3):1240-9. PubMed ID: 18947905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha sphere filter method: Application of pseudomolecular descriptors in virtual screening of 2D chemical structures.
    Muta H; Hirayama N
    J Comput Chem; 2010 Aug; 31(11):2225-32. PubMed ID: 20340104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovering potassium channel blockers from synthetic compound database by using structure-based virtual screening in conjunction with electrophysiological assay.
    Liu H; Gao ZB; Yao Z; Zheng S; Li Y; Zhu W; Tan X; Luo X; Shen J; Chen K; Hu GY; Jiang H
    J Med Chem; 2007 Jan; 50(1):83-93. PubMed ID: 17201412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of Pharmacophore Matching, 2D Similarity Search, and In Vitro Biological Assays in the Selection of Potential 5-HT6 Antagonists from Large Commercial Repositories.
    Dobi K; Flachner B; Pukáncsik M; Máthé E; Bognár M; Szaszkó M; Magyar C; Hajdú I; Lőrincz Z; Simon I; Fülöp F; Cseh S; Dormán G
    Chem Biol Drug Des; 2015 Oct; 86(4):864-80. PubMed ID: 25823681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-based molecular modeling study on a chemically diverse series of cholecystokinin-B/gastrin receptor antagonists: generation of predictive model.
    Chopra M; Mishra AK
    J Chem Inf Model; 2005; 45(6):1934-42. PubMed ID: 16309300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT(1A), 5-HT(2A), and 5-HT(7) serotonin receptor ligands.
    Chłoń-Rzepa G; Zmudzki P; Zajdel P; Bojarski AJ; Duszyńska B; Nikiforuk A; Tatarczyńska E; Pawłowski M
    Bioorg Med Chem; 2007 Aug; 15(15):5239-50. PubMed ID: 17517514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
    Caliendo G; Fiorino F; Perissutti E; Severino B; Gessi S; Cattabriga E; Borea PA; Santagada V
    Eur J Med Chem; 2001; 36(11-12):873-86. PubMed ID: 11755230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques.
    Ebalunode JO; Ouyang Z; Liang J; Zheng W
    J Chem Inf Model; 2008 Apr; 48(4):889-901. PubMed ID: 18396858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow.
    Markt P; Feldmann C; Rollinger JM; Raduner S; Schuster D; Kirchmair J; Distinto S; Spitzer GM; Wolber G; Laggner C; Altmann KH; Langer T; Gertsch J
    J Med Chem; 2009 Jan; 52(2):369-78. PubMed ID: 19143566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.